Edition:
United States

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

0.95USD
23 May 2018
Change (% chg)

$0.00 (+0.52%)
Prev Close
$0.95
Open
$0.98
Day's High
$0.98
Day's Low
$0.95
Volume
36,199
Avg. Vol
49,666
52-wk High
$2.83
52-wk Low
$0.78

Latest Key Developments (Source: Significant Developments)

Delmar Appoints Saiid Zarrabian Full-Time President And CEO
Tuesday, 22 May 2018 05:30am EDT 

May 22 (Reuters) - DelMar Pharmaceuticals Inc ::DELMAR APPOINTS SAIID ZARRABIAN TO FULL-TIME PRESIDENT AND CEO.DELMAR PHARMACEUTICALS - ZARRABIAN HAD PREVIOUSLY SERVED AS INTERIM PRESIDENT AND CEO SINCE NOVEMBER 2017.  Full Article

Delmar Pharmaceuticals To Increase Number Of Authorized Shares Of Stock, Par Value Of $0.001, Per Share From 50 Mln Shares To 70 Mln Shares
Friday, 13 Apr 2018 04:25pm EDT 

April 13 (Reuters) - DelMar Pharmaceuticals Inc ::TO INCREASE NUMBER OF AUTHORIZED SHARES OF STOCK, PAR VALUE OF $0.001, PER SHARE FROM 50 MILLION SHARES TO 70 MILLION SHARES.  Full Article

Delmar Pharmaceuticals' interim CEO Saiid​ ‍Zarrabian reports purchase of 60,900 shares of co's common stock on Nov 14
Thursday, 16 Nov 2017 04:45pm EST 

Nov 16 (Reuters) - Delmar Pharmaceuticals Inc :Delmar Pharmaceuticals Inc interim CEO Saiid​ ‍Zarrabian reports purchase of 60,900 shares of co's common stock on nov 14 - SEC Filing.  Full Article

Delmar Pharmaceuticals names Saiid Zarrabian interim CEO
Tuesday, 7 Nov 2017 04:05pm EST 

Nov 7 (Reuters) - Delmar Pharmaceuticals Inc :Delmar Pharmaceuticals appoints Saiid Zarrabian as interim chief executive officer.Jeffrey Bacha, cofounder of Co, will continue in role as president and in newly created position of chief operating officer​.Zarrabian and Bacha will continue to serve on company's board of directors​.  Full Article

DelMar Pharmaceuticals CEO Jeffrey​ Bacha buys 10,000 shares of co's common stock on Oct 6
Tuesday, 10 Oct 2017 08:15am EDT 

Oct 10 (Reuters) - DelMar Pharmaceuticals Inc :DelMar Pharmaceuticals Inc <<>> CEO Jeffrey​ Bacha reports open market puchase of 10,000 shares of co's common stock on Oct 6 - SEC filing.  Full Article

DelMar Pharmaceuticals wins approval for listing on NASDAQ
Monday, 11 Jul 2016 08:49am EDT 

Delmar Pharmaceuticals Inc : Delmar pharmaceuticals announces approval for listing on nasdaq .Delmar pharmaceuticals says stock will begin trading on nasdaq capital market at opening of trading on tuesday, july 12, 2016 under ticker symbol dmpi.  Full Article